TD Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

TD Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-18,000	Closed	-$425K	–	1418
2016 Q2	$425K	Sell	18,000 -600	-3%	-$14.8K	﹤0.01%	1166
2016 Q1	$379K	Buy	18,600 +10,700	+135%	+$339K	﹤0.01%	1173
2015 Q4	$406K	Sell	7,900 -3,900	-33%	-$189K	﹤0.01%	1161
2015 Q3	$503K	Buy	11,800 +700	+6%	+$33.8K	﹤0.01%	1065
2015 Q2	$506K	Buy	11,100 +200	+2%	+$8.05K	﹤0.01%	1108
2015 Q1	$414K	Hold	10,900	–	–	﹤0.01%	1157
2014 Q4	$309K	Sell	10,900 -800	-7%	-$22.2K	﹤0.01%	1219
2014 Q3	$296K	Sell	11,700 -5,300	-31%	-$140K	﹤0.01%	1156
2014 Q2	$496K	Sell	17,000 -800	-4%	-$19.4K	﹤0.01%	1032
2014 Q1	$461K	Hold	17,800	–	–	﹤0.01%	1060
2013 Q4	$458K	Hold	17,800	–	–	﹤0.01%	1040
2013 Q3	$476K	Buy	+17,800	New	+$424K	﹤0.01%	988

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TD Asset Management's PTLA Position: Q3 2016 in Review

TD Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2016, closing a stake of 18,000 shares — an estimated $425K sold.

TD Asset Management first reported a position in PTLA in Q3 2013 and held it in 12 quarters. The position peaked at $506K in Q2 2015. 151 funds tracked by Wall St. Rank hold PTLA as of Q3 2016.

TD Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
TD Asset Management sold 18,000 Portola Pharmaceuticals, Inc. shares in Q3 2016, an estimated $425K.
TD Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and held it in 12 quarters.
TD Asset Management's Portola Pharmaceuticals, Inc. position peaked at $506K in Q2 2015.
151 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2016.

Based on TD Asset Management's 13F filing for Q3 2016, filed 2 Nov 2016.